CD274 and neoplasm: Further, an integration of durvalumab-specific hybrid imaging before and within durvalumab maintenance treatment will be of interest to clarify a predictive and prognostic role of PD-L1 positive durvalumab-avid tumor and immunocompetent cell populations [42, 43].